Survival benefit of extended resection in pancreatic cancer

American Journal of Surgery

Volumn 194, Issue 4 SUPPL., 2007, Pages

  Büchler, Peter ^a,b   Friess, Helmut ^b   Müller, Michael ^b   AlKhatib, Jaber ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Pancreatic cancer; Radical resection; Surgery; Survival; Vascular resection

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LYMPH NODE DISSECTION; METASTASIS; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; SURGICAL APPROACH; TREATMENT OUTCOME;

EID: 34548845066     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.05.022     Document Type: Article

References (73)

1. Kazanjian K.K., Hines O.J., Eibl G., et al. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg 140 (2005) 849-854
2. Cameron J.L., Riall T.S., Coleman J., et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg 244 (2006) 10-15
3. Buchler M.W., Wagner M., Schmied B.M., et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138 (2003) 1310-1314
4. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140 (2006) 764-772
5. Cress R.D., Yin D., Clarke L., et al. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control 17 (2006) 403-409
6. Fesinmeyer M.D., Austin M.A., Li C.I., et al. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1766-1773
7. Wagner M., Redaelli C., Lietz M., et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91 (2004) 586-594
8. Trede M., Saeger H.D., Schwall G., et al. Resection of pancreatic cancer-surgical achievements. Langenbecks Arch Surg 383 (1998) 121-128
9. Allema J.H., Reinders M.E., van Gulik T.M., et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 75 (1995) 2069-2076
10. Kim H.J., Czischke K., Brennan M.F., et al. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?. J Gastrointest Surg 6 (2002) 763-769
11. Neoptolemos J.P., Stocken D.D., Dunn J.A., et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234 (2001) 758-768
12. Seiler C.A., Wagner M., Sadowski C., et al. Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 4 (2000) 443-452
13. Lin P.W., Shan Y.S., Lin Y.J., et al. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 52 (2005) 1601-1604
14. Lin P.W., and Lin Y.J. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 86 (1999) 603-607
15. Tran K.T., Smeenk H.G., van Eijck C.H., et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240 (2004) 738-745
16. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
17. Seiler C.A., Wagner M., Schaller B., et al. [Pylorus preserving or classical Whipple operation in tumors. Initial clinical results of a prospective randomized study]. Swiss Surg 6 (2000) 275-282
18. Seiler C.A., Wagner M., Bachmann T., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
19. Bell Jr. R.H. Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes. Cancer Treat Rev 31 (2005) 328-331
20. Pedrazzoli S., Beger H.G., Obertop H., et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 16 (1999) 337-345
21. Jones L., Russell C., Mosca F., et al. Standard Kausch-Whipple pancreatoduodenectomy. Dig Surg 16 (1999) 297-304
22. Kayahara M., Nagakawa T., Ueno K., et al. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72 (1993) 2118-2123
23. Delcore R., Rodriguez F.J., Forster J., et al. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 172 (1996) 463-468
24. Amikura K., Kobari M., and Matsuno S. The time of occurrence of liver metastasis in carcinoma of the pancreas. Int J Pancreatol 17 (1995) 139-146
25. Karpoff H.M., Klimstra D.S., Brennan M.F., et al. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 136 (2001) 44-47
26. Nagakawa T., Kobayashi H., Ueno K., et al. The pattern of lymph node involvement in carcinoma of the head of the pancreas: a histologic study of the surgical findings in patients undergoing extensive nodal dissections. Int J Pancreatol 13 (1993) 15-22
27. Nagakawa T., Kayahara M., Ohta T., et al. Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol 10 (1991) 113-119
28. Nagakawa T., Mori K., Nakano T., et al. Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 80 (1993) 619-621
29. Nagai H., Kuroda A., and Morioka Y. Lymphatic and local spread of T1 and T2 pancreatic cancer: a study of autopsy material. Ann Surg 204 (1986) 65-71
30. Nakao A., Harada A., Nonami T., et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 12 (1996) 357-361
31. Verbeke C.S., Leitch D., Menon K.V., et al. Redefining the R1 resection in pancreatic cancer. Br J Surg 93 (2006) 1232-1237
32. Heald R.J., Husband E.M., and Ryall R.D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg 69 (1982) 613-616
33. Cecil T.D., Sexton R., Moran B.J., et al. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 47 (2004) 1145-1149
34. Fortner J.G. Recent advances in pancreatic cancer. Surg Clin North Am 54 (1974) 859-863
35. Tsuchiya R., and Tsunoda T. Tumor size as a predictive factor. Int J Pancreatol 7 (1990) 117-123
36. Ishikawa O., Ohhigashi H., Sasaki Y., et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 208 (1988) 215-220
37. Satake K., Nishiwaki H., Yokomatsu H., et al. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 175 (1992) 259-265
38. Nakao A., Harada A., Nonami T., et al. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery 117 (1995) 50-55
39. Henne-Bruns D., Kremer B., Meyer-Pannwitt U., et al. Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: initial results. Hepatogastroenterology 40 (1993) 145-149
40. Mukaiya M., Hirata K., Satoh T., et al. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan. World J Surg 22 (1998) 248-252
41. Yeo C.J. The Johns Hopkins experience with pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. J Gastrointest Surg 4 (2000) 231-232
42. Deki H., and Sato T. An anatomic study of the peripancreatic lymphatics. Surg Radiol Anat 10 (1988) 121-135
43. O'Morchoe C.C. Lymphatic system of the pancreas. Microsc Res Tech 37 (1997) 456-477
44. Ungeheuer A., and Liebermann-Meffert D. [An anatomic study of the pancreatic lymphatics. Review of the summary and an abridged version of the original text]. Langenbecks Arch Chir 375 (1990) 303-307
45. Kayahara M., Nagakawa T., Kobayashi H., et al. Lymphatic flow in carcinoma of the head of the pancreas. Cancer 70 (1992) 2061-2066
46. Nagakawa T., Konishi I., Ueno K., et al. A clinical study on lymphatic flow in carcinoma of the pancreatic head area-peripancreatic regional lymph node grouping. Hepatogastroenterology 40 (1993) 457-462
47. Nakao A., Harada A., Nonami T., et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg 84 (1997) 1090-1092
48. Gazzaniga G.M., Cappato S., Papadia F., et al. D1 versus D2 pancreatoduodenectomy in surgical therapy of pancreatic head cancer. Hepatogastroenterology 48 (2001) 1471-1478
49. Iacono C., Accordini S., Bortolasi L., et al. Results of pancreaticoduodenectomy for pancreatic cancer: extended versus standard procedure. World J Surg 26 (2002) 1309-1314
50. Popiela T., Kedra B., and Sierzega M. Does extended lymphadenectomy improve survival of pancreatic cancer patients?. Acta Chir Belg 102 (2002) 78-82
51. Capussotti L., Massucco P., Ribero D., et al. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138 (2003) 1316-1322
52. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228 (1998) 508-517
53. Yeo C.J., Cameron J.L., Sohn T.A., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229 (1999) 613-622
54. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355-366
55. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg 9 (2005) 1191-1204
56. Nguyen T.C., Sohn T.A., Cameron J.L., et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 7 (2003) 1-9
57. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 (2005) 618-8
58. Nagino M., and Nimura Y. [Dose "extended" surgery for pancreatic head adenocarcinoma have survival impact?]. Nippon Geka Gakkai Zasshi 107 (2006) 173-176
59. Pawlik T.M., Abdalla E.K., Barnett C.C., et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140 (2005) 584-589
60. Pisters P.W., Evans D.B., Leung D.H., et al. Re: surgery for ductal adenocarcinoma of the pancreatic head. World J Surg 25 (2001) 533-534
61. Roder J.D., Stein H.J., and Siewert J.R. Carcinoma of the periampullary region: who benefits from portal vein resection?. Am J Surg 171 (1996) 170-174
62. Fuhrman G.M., Leach S.D., Staley C.A., et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223 (1996) 154-162
63. Takahashi S., Ogata Y., and Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 81 (1994) 1190-1193
64. Harrison L.E., Klimstra D.S., and Brennan M.F. Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication for resection?. Ann Surg 224 (1996) 342-347
65. Harrison L.E., and Brennan M.F. Portal vein involvement in pancreatic cancer: a sign of unresectability?. Adv Surg 31 (1997) 375-394
66. Leach S.D., Lee J.E., Charnsangavej C., et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85 (1998) 611-617
67. Siriwardana H.P., and Siriwardena A.K. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93 (2006) 662-673
68. Bachellier P., Nakano H., Oussoultzoglou P.D., et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?. Am J Surg 182 (2001) 120-129
69. Sasson A.R., Hoffman J.P., Ross E.A., et al. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?. J Gastrointest Surg 6 (2002) 147-157
70. Nakagohri T., Kinoshita T., Konishi M., et al. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186 (2003) 149-153
71. van Geenen R.C., ten Kate F.J., De Wit L.T., et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 129 (2001) 158-163
72. Shrikhande S.V., Kleeff J., Reiser C., et al. Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14 (2007) 118-127
73. Classification of regional lymph nodes in Japan. Int J Clin Oncol 8 (2003) 248-275